Perampanel ( DrugBank: Perampanel )

3 diseases

ID	Disease name (Link within this page)	Number of trials
2	Amyotrophic lateral sclerosis	6
6	Parkinson disease	4
144	Lennox-Gastaut syndrome	10

2. Amyotrophic lateral sclerosis

Clinical trials : 645 / Drugs : 589 - (DrugBank : 163) / Drug target genes : 150 - Drug target pathways : 225

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03377309 (ClinicalTrials.gov)	December 1, 2019	14/12/2017	Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients	Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients	Amyotrophic Lateral Sclerosis	Drug: Fycompa	American University of Beirut Medical Center	NULL	Terminated	18 Years	80 Years	All	6	Phase 2	Lebanon
2	NCT03793868 (ClinicalTrials.gov)	December 4, 2018	28/12/2018	PerampanelSingle Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lat ...	PerampanelSingle Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lat ...	Amyotrophic Lateral Sclerosis	Drug: Perampanel;Other: Placebo	Mayo Clinic	NULL	Completed	18 Years	70 Years	All	22	Early Phase 1	United States
3	JPRN-UMIN000025614	2017/04/24	01/02/2017	Perampanelfor sporadic amyotrophic lateral sclerosis (ALS): A Multicenter, Randomized, Double-blind, ...	Perampanelfor sporadic amyotrophic lateral sclerosis (ALS): A Multicenter, Randomized, Double-blind, ...	Sporadic amyotrophic lateral sclerosis	Once daily perampanelwith dose-escalation tolerable from 2mg to 4mg for 48 weeks (Interventions) Once ...	Department of Neurology, Tokyo Medical University	NULL	Complete: follow-up complete	40years-old	78years-old	Male and Female	60	Phase 2	Japan
4	NCT03019419 (ClinicalTrials.gov)	April 24, 2017	10/1/2017	Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)	Perampanelfor Sporadic Amyotrophic Lateral Sclerosis (ALS): A Multicenter, Randomized, Double-blind, ...	ALS	Drug: Perampanel;Drug: placebo	Tokyo Medical University	NULL	Completed	40 Years	78 Years	All	66	Phase 2	Japan
5	JPRN-UMIN000026221	2017/03/02	01/03/2017	Safety of perampanel in patients with motor neuron disease	Safety of perampanelin patients with motor neuron disease - Safety of perampanelin patients with mot ...	amyotrophic lateral sclerosis	Once daily perampanel with dose escalation from 2mg to 8mg.	Department of Neurology, Juntendo University School of Medicine	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	15	Phase 1	Japan
6	NCT03020797 (ClinicalTrials.gov)	January 12, 2017	15/12/2016	A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral ...		Amyotrophic Lateral Sclerosis	Drug: Perampanel;Drug: Placebo Oral Tablet	Stony Brook University	Eisai Inc.	Recruiting	18 Years	80 Years	All	60	N/A	United States

First Previous1Next Last

6. Parkinson disease

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00566462 (ClinicalTrials.gov)	October 2007	29/11/2007	Assessment of Perampanel(E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study Wit ...	Assessment of Perampanel(E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study Wit ...	Parkinson's Disease	Drug: perampanel;Drug: placebo	Eisai Inc.	NULL	Terminated	30 Years	N/A	All	1	Phase 2	United States
2	NCT00505622 (ClinicalTrials.gov)	July 2007	9/7/2007	Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel(E2007) as an Adjunctive ...	A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability, and Effic ...	Parkinson's Disease	Drug: Perampanel	Eisai Limited	NULL	Terminated	30 Years	N/A	All	328	Phase 3	France
3	NCT00368108 (ClinicalTrials.gov)	August 2006	22/8/2006	Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Mo ...	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy, ...	Parkinson's Disease	Drug: 2 mg perampanel;Drug: 4 mg perampanel;Drug: placebo comparator	Eisai Inc.	NULL	Completed	30 Years	N/A	All	752	Phase 3	United States;Canada
4	NCT01634360 (ClinicalTrials.gov)	November 2004	3/7/2012	Long-Term Safety, Tolerability and Efficacy in PerampanelTreated Parkinson's Disease Patients With M ...	A 48-month Open Label Multi-centered Extension Study to Evaluate the Long-term Safety, Tolerability ...	Parkinson's Disease	Drug: Perampanel	Eisai Inc.	NULL	Terminated	N/A	N/A	All	185	Phase 2	NULL

First Previous1Next Last

144. Lennox-Gastaut syndrome

Clinical trials : 111 / Drugs : 72 - (DrugBank : 14) / Drug target genes : 49 - Drug target pathways : 61

diseases per page:

Showing 1 to 10 of 10 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-002321-35-BE (EUCTR)	05/06/2018	25/04/2017	A global study completed at hospitals in US, Europe & Asia using an investigational drug (Perampanel ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase ...	Seizures associated with Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.1;Level: PT;Classification ...	Trade Name: Fycompa Product Name: perampanel Product Code: E2007 INN or Proposed INN: perampanel Other d ...	Eisai Limited	NULL	Not Recruiting			Female: yes Male: yes	142	Phase 3	United States;France;Hungary;Czech Republic;Canada;Poland;Belgium;Australia;Latvia;Japan;Italy;Korea ...
2	EUCTR2014-002321-35-IT (EUCTR)	01/09/2017	20/01/2022	A global study completed at hospitals in US, Europe & Asia using an investigational drug (Perampanel ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With anOpen-Label Extension Phase ...	Seizures associated with Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.1;Level: PT;Classification ...	Trade Name: Fycompa INN or Proposed INN: PERAMPANEL Other descriptive name: PERAMPANEL Trade Name: Fyco ...	EISAI LIMITED	NULL	Not Recruiting			Female: yes Male: yes	142	Phase 3	United States;Czechia;Korea, Democratic People's Republic of;Lithuania;Italy;France;Czech Republic;H ...
3	EUCTR2014-002321-35-CZ (EUCTR)	31/08/2017	26/05/2017	A global study completed at hospitals in US, Europe & Asia using an investigational drug (Perampanel ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase ...	Seizures associated with Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.1;Level: PT;Classification ...	Trade Name: Fycompa Product Name: perampanel Product Code: E2007 INN or Proposed INN: perampanel Other d ...	Eisai Limited	NULL	Not Recruiting			Female: yes Male: yes	142	Phase 3	United States;Czechia;Italy;France;Czech Republic;Hungary;Canada;Belgium;Poland;Australia;Latvia;Jap ...
4	EUCTR2014-002321-35-LV (EUCTR)	26/05/2017	09/05/2017	A global study completed at hospitals in US, Europe & Asia using an investigational drug (Perampanel ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase ...	Seizures associated with Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.0;Level: PT;Classification ...	Trade Name: Fycompa Product Name: perampanel Product Code: E2007 INN or Proposed INN: perampanel Other d ...	Eisai Limited	NULL	Not Recruiting			Female: yes Male: yes	142	Phase 3	France;United States;Hungary;Czech Republic;Canada;Poland;Belgium;Australia;Latvia;Japan;Italy;Korea ...
5	EUCTR2014-002321-35-HU (EUCTR)	08/05/2017	20/04/2017	A global study completed at hospitals in US, Europe & Asia using an investigational drug (Perampanel ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase ...	Seizures associated with Lennox-Gastaut Syndrome (LGS) MedDRA version: 19.1;Level: PT;Classification ...	Trade Name: Fycompa Product Name: perampanel Product Code: E2007 INN or Proposed INN: perampanel Other d ...	Eisai Limited	NULL	Not Recruiting			Female: yes Male: yes	142	Phase 3	United States;France;Czech Republic;Hungary;Canada;Poland;Belgium;Australia;Latvia;Japan;Italy;Korea ...
6	NCT02834793 (ClinicalTrials.gov)	December 13, 2016	13/7/2016	Study of Perampanelas Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lenn ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase ...	Lennox-Gastaut Syndrome (LGS)	Drug: Placebo;Drug: Perampanel	Eisai Inc.	NULL	Terminated	2 Years	N/A	All	70	Phase 3	Czechia;India;Japan;Korea, Republic of;Australia;Belgium;United States;Austria
7	JPRN-JapicCTI-173536	13/12/2016	15/03/2017	Study of Perampanelas Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lenn ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase ...	Lennox-Gastaut Syndrome (LGS)	Intervention name : E2007 INN of the intervention : Perampanel Dosage And administration of the interv ...	Eisai Co., Ltd.	NULL	complete	2		BOTH	142	Phase 3	Japan, Asia except Japan, North America, Europe, Oceania
8	NCT02307578 (ClinicalTrials.gov)	February 5, 2015	2/12/2014	An Extended Access Program (EAP) for Perampanel	An Extended Access Program (EAP) for Perampanel	Primary Generalized Tonic-Clonic or Partial Onset Seizures;Lennox Gastaut Syndrome	Drug: Perampanel	Eisai Inc.	NULL	Available	1 Year	N/A	All			Belgium;Chile;Estonia;Hungary;Latvia;Lithuania;Poland;Spain
9	EUCTR2014-002321-35-FR (EUCTR)		21/02/2018	A global study completed at hospitals in US, Europe & Asia using an investigational drug (Perampanel ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase ...	Seizures associated with Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.1;Level: PT;Classification ...	Trade Name: Fycompa Product Name: perampanel Product Code: E2007 INN or Proposed INN: perampanel Other d ...	Eisai Limited	NULL	Not Recruiting			Female: yes Male: yes	142	Phase 3	United States;France;Hungary;Czech Republic;Canada;Poland;Belgium;Australia;Latvia;Japan;Italy;Korea ...
10	EUCTR2014-002321-35-PL (EUCTR)		13/05/2017	A global study completed at hospitals in US, Europe & Asia using an investigational drug (Perampanel ...	A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase ...	Seizures associated with Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.0;Level: PT;Classification ...	Trade Name: Fycompa Product Name: perampanel Product Code: E2007 INN or Proposed INN: perampanel Other d ...	Eisai Limited	NULL	Not Recruiting			Female: yes Male: yes	142	Phase 3	United States;France;Hungary;Czech Republic;Canada;Belgium;Poland;Australia;Latvia;Japan;Italy;Korea ...

First Previous1Next Last